Literature DB >> 25486186

Inducible drug modification: a new form of resistance.

Biljana Culjkovic-Kraljacic1, Hiba Ahmad Zahreddine, Katherine Lb Borden.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25486186      PMCID： PMC4614680          DOI： 10.4161/15384101.2014.946372

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  7 in total

1.  The Equilibrative Nucleoside Transporter (ENT1) can be phosphorylated at multiple sites by PKC and PKA.

Authors:  German Reyes; Nicole M I Nivillac; Muhammad Zia Karim; Leroi Desouza; K W Michael Siu; Imogen R Coe
Journal:  Mol Membr Biol       Date:  2011-08-02       Impact factor: 2.857

2.  Ribavirin treatment effects on breast cancers overexpressing eIF4E, a biomarker with prognostic specificity for luminal B-type breast cancer.

Authors:  Filippa Pettersson; Christina Yau; Monica C Dobocan; Biljana Culjkovic-Kraljacic; Hélène Retrouvey; Hélène Retrouvay; Rachel Puckett; Ludmila M Flores; Ian E Krop; Caroline Rousseau; Eftihia Cocolakis; Katherine L B Borden; Christopher C Benz; Wilson H Miller
Journal:  Clin Cancer Res       Date:  2011-03-17       Impact factor: 12.531

3.  Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap.

Authors:  Alex Kentsis; Ivan Topisirovic; Biljana Culjkovic; Ling Shao; Katherine L B Borden
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-15       Impact factor: 11.205

4.  Glucuronidation as a mechanism of intrinsic drug resistance in human colon cancer: reversal of resistance by food additives.

Authors:  Jeffrey Cummings; Brian T Ethell; Lesley Jardine; Gary Boyd; Janet S Macpherson; Brian Burchell; John F Smyth; Duncan I Jodrell
Journal:  Cancer Res       Date:  2003-12-01       Impact factor: 12.701

5.  Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin.

Authors:  Sarit Assouline; Biljana Culjkovic; Eftihia Cocolakis; Caroline Rousseau; Nathalie Beslu; Abdellatif Amri; Stephen Caplan; Brian Leber; Denis-Claude Roy; Wilson H Miller; Katherine L B Borden
Journal:  Blood       Date:  2009-05-11       Impact factor: 22.113

6.  Mechanisms and insights into drug resistance in cancer.

Authors:  Hiba Zahreddine; Katherine L B Borden
Journal:  Front Pharmacol       Date:  2013-03-14       Impact factor: 5.810

7.  The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation.

Authors:  Hiba Ahmad Zahreddine; Biljana Culjkovic-Kraljacic; Sarit Assouline; Patrick Gendron; Andrea A Romeo; Stephen J Morris; Gregory Cormack; James B Jaquith; Leandro Cerchietti; Eftihia Cocolakis; Abdellatif Amri; Julie Bergeron; Brian Leber; Michael W Becker; Shanshan Pei; Craig T Jordan; Wilson H Miller; Katherine L B Borden
Journal:  Nature       Date:  2014-05-28       Impact factor: 49.962
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.